NCT05982379

Brief Summary

Purpose: To determine the effectiveness of the technology-based motivation program implemented with children with cancer diagnosis and their primary caregivers. Methods: This randomized controlled trial was completed with 31 children and 31 primary caregivers between the ages of 9 and18, who were being treated for cancer. A 10-week "Technology Based Motivation Program" was given to the intervention group. "State/ Trait Anxiety Inventory for Children", "Paediatric Quality of Life Inventory", "Paediatric Cancer Coping Scale", "State and Trait Anxiety Inventory," and "Process Evaluation Forms" were administered. Chi-square test, Fisher-Exact test, Independent Sample-t test, Man-Whitney U test, Wilcoxon test, Pearson and Spearman correlation coefficients were used for data analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 2, 2019

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2020

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

July 25, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 8, 2023

Completed
Last Updated

August 8, 2023

Status Verified

August 1, 2023

Enrollment Period

9 months

First QC Date

July 25, 2023

Last Update Submit

August 1, 2023

Conditions

Keywords

CancerChildMotivationProgramParentPsychosocialTechnology

Outcome Measures

Primary Outcomes (4)

  • Anxiety levels of the children

    State/ Trait Anxiety Inventory for Children: 20 items for the State Anxiety, 20 items for the Trait Anxiety. The scores on the scale range from 20 to 60, and a high score indicates high anxiety.

    baseline (Initial interview) and through study completion (10th week)

  • Children's quality of life scores

    Pediatric Quality of Life Inventory: The scale consists of 23 items and is scored from 0 to 100. The higher the score, the higher the quality of life

    baseline (Initial interview) and through study completion (10th week)

  • Coping scores of the children

    Pediatric Cancer Coping Scale:The scale comprises 33 items related to cognitive coping, problem oriented coping, and defensive coping.The score obtained from the scale ranges from 0 to 99. Higher scores on the scale indicate a high level of coping strategies.

    baseline (Initial interview) and through study completion (10th week)

  • Anxiety levels of the primary caregivers

    Spielberger State/ Trait Anxiety Inventory: 20 items of the 40-item scale are used to determine state anxiety and 20 items are used to determine trait anxiety.The scores on the scale range from 20 to 80, and the higher the score, the higher the level of anxiety.

    baseline (Initial interview) and through study completion (10th week)

Secondary Outcomes (1)

  • Application tracking forms

    Every week during the intervention

Study Arms (2)

Intervention

EXPERIMENTAL

This study was carried out with two groups. Technology Based Motivation Program were used for the intervention group.

Other: Technology Based Motivation Program

Control

NO INTERVENTION

No application was made to the control group, standard procedure was followed.

Interventions

A 10-week "Technology Based Motivation Program" was given to the intervention group. The website and four training modules were used with the children in the intervention group. Nine coaching interviews with each child (once a week) were conducted over WhatsApp. The children were encouraged to do progressive relaxation and breathing exercises at least twice a week, and eight therapeutic stories (once a week) were sent to the child's phone in the form of animation. Three training modules were used with the primary caregivers, and coaching interviews were conducted on WhatsApp twice during the program. Primary caregivers practiced progressive relaxation and breathing exercises at least twice a week. In addition, eight motivation messages were sent to the child and primary caregiver, and 24/7 consultancy was provided.

Intervention

Eligibility Criteria

Age9 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • For children:
  • Those having received cancer treatment (leukaemia, lymphomas and solid tumours),
  • Those aged 9-18 years,
  • Those who speak Turkish,
  • Those who have internet access on their smart phone or computer,
  • Self and primary caregiver having agreed to participate in the study, and
  • Those who can continue the research for 9 weeks (Trying progressive relaxation exercises, breathing exercises and imagination at least twice a week).
  • For primary caregivers:
  • Those who speak Turkish,
  • Those who are literate,
  • Those who have internet access on their smart phones and computers,
  • Those who agree to participate in the research, and
  • Those who can continue the research for 9 weeks (Trying progressive relaxation exercises at least twice a week).

You may not qualify if:

  • Those who do not agree to participate in the research,
  • Those who have experienced significant life events in the last 6 months (migration, death, divorce etc.),
  • The presence of another important disease in the family that can increase stress and prevent coping, and
  • Those who do not have internet access.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zeynep Kisecik Şengül

Kırıkkale, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Zeynep Kisecik Şengül, RN, PhD

    Kırıkkale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Among the identified strata, intervention and control groups were randomized by an independent statistician using the website www.randomizer.org. The data of the study were entered by a person other than the researcher. Statistical analysis was performed by a person other than the researcher.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: A randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 25, 2023

First Posted

August 8, 2023

Study Start

September 2, 2019

Primary Completion

June 1, 2020

Study Completion

August 28, 2020

Last Updated

August 8, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

The confidentiality of the data used in the study will be protected.

Locations